Autor: "Yeung CCS" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker.
Autorzy:: Reddi D; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA. .
Seaton BW; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Woolston D; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Aicher L; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Monroe LD; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Mao ZJ; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Harrell JC; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Radich JP; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Advani A; Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA.
Papadantonakis N; Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Yeung CCS; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, USA.; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Apr 06; Vol. 12 (1), pp. 5809. Date of Electronic Publication: 2022 Apr 06.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/genetics
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma*/metabolism
Aldo-Keto Reductase Family 1 Member C3 ; Animals ; Biomarkers ; Bone Marrow/metabolism ; Humans ; Immunohistochemistry ; Mice

Czasopismo naukowe

Informacja